🔎 Trials Near Me

Utama › Penyakit Hati Steatotik › Texas › Houston

Kajian klinikal Penyakit Hati Steatotik di Houston, TX

13 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Mengambil pesertaFasa 3
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Mengambil pesertaFasa 3
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • dan 1 lagi
Umur 18 hingga 80 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Bellaire · 7 mi jauh
  • GSK Investigational Site, Humble · 17 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Bellaire · 7 mi jauh
  • GSK Investigational Site, Humble · 17 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07701993

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Mengambil pesertaFasa 3
  • HRI- Medical Center, Houston
  • Care Access - Houston, Houston
  • Houston Research Institute, Houston
  • dan 3 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Mengambil pesertaFasa 3
  • Akero Clinical Study Site, Houston
  • Akero Clinical Study Site, Houston
  • Akero Clinical Study Site, Houston
  • dan 3 lagi
Umur 18 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Mengambil pesertaFasa 2
  • Houston Research Institute - Medical Center, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, Bellaire · 7 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07288138

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Mengambil pesertaFasa 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Bellaire · 7 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Mengambil pesertaFasa 2
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
  • Pioneer Research Solutions, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT05648214

NAFLD Clinical Care Pathway

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT06671886

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Mengambil pesertaKajian pemerhatian
  • First Surgical Hospital, Bellaire · 7 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Ogo 2025 · NCT07122700

Kajian Penyakit Hati Steatotik di bandar lain

Kajian lain di Houston

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.